Key Objectives of the Portfolio Analysis & Optimization Process

1. Value vs Cost 
   Understanding the potential value and associated costs of compounds in the R&D pipeline
    

2. Depth of Understanding
   Gain concrete knowledge of the scientific and commercial issues facing each compound in clinical development
    

3. Choices and Agreement
   Prioritize late-stage and line-extension projects for funding
   Agree on those novel compounds which will continue to be supported in early stages
    

4. Implications and Action
   Understand the implications of these portfolio choices on the operations and budgets of the company